secretory pathway during HSV1 cell entry as well as assembly. Group members Prof. Dr. rer. nat. Beate Sodeik Team leader Prof. Dr. rer. nat. Beate Sodeik Medizinische Hochschule Hannover (Hannover Medical [...] Simplex Virus - a hitch hiker’s guide to epithelial cells, neurons and immune cells Our group is interested in the cell biology of alpha herpesviruses. How does a virus get access to a cell, disassemble [...] 9/CV_Sodeik.pdf Dr. Sodeik studied biology in Bonn (1982-88), and obtained a Diploma in Cell Biology analyzing autophagy in the single cell animal Amoeba proteus. She then trained as a DAAD fellow (German

therapies as a primary phenotype. Once a potential marker is discovered, we not only focus on rigorous replication in clinical cohorts, but also try to understand how specific regulation of a particular [...] Paris INSERM (Centre Hospitalier Sainte Anne), Paris Research group members Research group leader Prof. Dr. med. Helge Frieling Deputy director & Founding member and scientific advisory board of the Research [...] proteins, the structure of DNA can be altered (chromatin remodeling) in such a way that individual genes are switched on and off in a spatio–temporal manner. Short RNA species and posttranscriptional RNA m

Weitere Informationen Impressum Herausgeber: Präsident der MHH Herr Prof. Dr. med. Michael P. Manns Forschungsdekan der MHH Herr Prof. Dr. med. Frank M. Bengel Bearbeitung und Ansprechpartner: Forschungsdekanat [...] critical for understanding the mechanisms of protection and for prioritisation of vaccines. Here, we used a unique collection of human specimens and HCV strains to develop HCV reference viruses for quantification

einem Team der Medizinischen Hochschule (MHH, PD Dr. K. Stahl), der Uniklinik Bonn (UKB, PD Dr. C. Bode) sowie dem Universitätsspital Zürich (USZ, Prof. Dr. S. David) gemeinsam geplant (EXCHANGE Studie mit [...] plasma exchange in septic shock: results from a randomized controlled trial. Stahl K, Wand P, Seeliger B, Wendel-Garcia PD, Schmidt JJ, Schmidt BMW, Sauer A, Lehmann F, Budde U, Busch M, Wiesner O, Welte [...] Beteiligung von 22 Zentren in Deutschland und der Schweiz). Weitere Informationen erhalten Sie bei PD Dr. Klaus Stahl, stahl.klaus @ mh-hannover.de , Telefon 0511-532-3305 Zum Originalartikel: 1. Clinical

2018 Dr. Rainer Niedenthal "A potential difference in the regulation of MK2 and MK3" Gebäude I3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 15.12.2017 Dr. Mark Windheim "The Adenovirus 19a E3/49K Protein: A Christmas [...] 2016 Prof. Dr. Helmut Holtmann "A translational silencing element in the IκBζ mRNA involves MCPIP1 and acts at a post-initiation event" Gebäude I 3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 10.06.2016 Prof. Dr [...] Update" Gebäude I3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 08.12.2017 Dr. Robert Freund "Investigating X1 - a MK2 substrate in striated muscle" Prof. Dr. Matthias Preller "Biophysical methods to study interactions

functional analysis as well as in the diagnostics of human malignancies of the blood. Employees Prof. Dr. med. Anke Katharina Bergmann (Lead) Jana Lentes, M.Sc. Zeljko Antic, MD Michelle Tang, PhD, Data Scientist [...] AG Personalisierte Genomik Lead: PD Dr. med. Anke Katharina Bergmann Molecular analyses and related data are getting more and more important to decipher the pathoetiology of complex and rare diseases. [...] RNA-seq, RRBS-seq, and WGBS-seq (partly single-cell) and transfering results into functional studies. A better knowledge of the causes of malignant transformation will ultimately enable to optimize risk

Frau Prof. Dr. K. Lange 2008 Menarini-Preis der Deutsche Diabetes-Gesellschaft (DDG) für herausragende wissenschaftliche Projekte in der Diabetestherapie und Forschung gemeinsam mit Frau Prof. Dr. K. Lange [...] Kim-Dorner, S. J.*, Berndt, V., Biester, T., Dehn-Hindenberg, A., Heidtmann, B., Jorch, N., Lilienthal, E., Nellen-Hellmuth, N., Neu, A., Schaaf, K., Ziegler, R., & Lange, K. (2022). Understanding daily [...] 1155/2022/9604115 Dehn-Hindenberg, A.*, Saßmann, H.*, Berndt, V., Biester, T., Heidtmann, B., Jorch, N., Kim-Dorner, S. J., Konrad, K., Lilienthal, E., Nellen-Hellmuth, N., Neu, A., Ziegler, R., & Lange, K. (2021)

verordnete und überwachte Therapie mit Cannabis-basierten Medikamenten erhalten würden. Zur Person: Prof. Dr. med. Kirsten Müller-Vahl ist Geschäftsführende Oberärztin in unserer Klinik für Psychiatrie, Sozi [...] Stand: 25. April 2023 Frau Prof. Müller-Vahl, die Bundesregierung hat ihre Pläne für ein Gesetz zur Legalisierung von Cannabis vorgestellt. Danach sind u. a. max. 25 Gramm Genuss-Cannabis als Besitz erlaubt

der Medizinischen Hochschule Hannover, im Besonderen dem Institutsleiter Herrn Prof. Dr. med . Roland Seifert, sowie Herrn Dr. Bastian Schirmer das Thema "Risiken und Nebenwirkungen bei Nahrungsergänzun [...] Lieferengpässe DGIM-Talk - Unverzichtbare Arzneimittel und Lieferengpässe Unser Institutsdirektor Prof. Dr. Seifert hat am 09.02.2026 an dem Talk - zum Thema "Unverzichtbare Arzneimittel und Lieferengpässe [...] Helsby NA, Izzo AA, Ostrom R, Pagano E, Papapetropoulos A, Pyne NJ, Pyne S, Robson T, Seifert R , Stasch JP, Szabo C, van der Stelt M, van der Vliet A, Watts V, Wong SS. The Concise Guide to PHARMACOLOGY

origins and path the way to personalized treatments of neurodevelopmental disorders and beyond .” Prof. Dr. med. Nataliya Di Donato Group leader, Director Department for Human Genetics Email | ORCID Research [...] it is estimated that a total of 27 to 36 million people suffer from a rare disease in Europe. Typically, rare diseases manifest early in life, sending children and their parents on a diagnostic odyssey for [...] actinopathies, genetic alterations are associated with a wide range of clinical manifestations. Although patients are diagnosed with the same disorder, only a subset exhibit specific symptoms. The underlying